Jack A. Khattar
President, CEO at Supernus Pharmaceuticals Inc.
Sits on 3 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 3 boards, counting each seat separately. Longest: Supernus Pharmaceuticals Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Supernus Pharmaceuticals Inc. June 16, 202597.9%
-
Cognition Therapeutics Inc. June 7, 202484.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 2, 2026 | Indivior Pharmaceuticals Inc. | Other | +1,937,986 | — | — |
| Nov 2, 2026 | Supernus Pharmaceuticals Inc. | Other | −1,258,351 | — | — |
| Nov 2, 2026 | Indivior Pharmaceuticals Inc. | Other | +1,475,569 | — | — |
| Nov 2, 2026 | Supernus Pharmaceuticals Inc. | Other | −958,100 | — | — |
| Aug 12, 2026 | Supernus Pharmaceuticals Inc. | Option exercise | +29,849 | — | — |
| Aug 12, 2026 | Supernus Pharmaceuticals Inc. | Shares withheld for tax | −12,642 | $46.57 | $588,738 |
| Jun 17, 2026 | Cognition Therapeutics Inc. | Grant or award | +25,000 | — | — |
| Mar 13, 2026 | Supernus Pharmaceuticals Inc. | Other | +12,500 | — | — |
| Mar 13, 2026 | Supernus Pharmaceuticals Inc. | Other | −12,500 | — | — |
| Mar 13, 2026 | Supernus Pharmaceuticals Inc. | Open-market sale | −24,138 | $50.09 | $1,209,072 |
| Mar 13, 2026 | Supernus Pharmaceuticals Inc. | Open-market sale | −10,742 | $51.00 | $547,842 |
| Mar 13, 2026 | Supernus Pharmaceuticals Inc. | Open-market sale | −120 | $51.75 | $6,210 |
| Mar 6, 2026 | Supernus Pharmaceuticals Inc. | Option exercise | +38,640 | — | — |
| Mar 6, 2026 | Supernus Pharmaceuticals Inc. | Shares withheld for tax | −16,574 | $54.73 | $907,095 |
| Oct 9, 2025 | Supernus Pharmaceuticals Inc. | Option exercise | +81,250 | $25.30 | $2,055,625 |
Questions about Jack A. Khattar
What boards is Jack A. Khattar on?
Jack A. Khattar sits on the boards of Cognition Therapeutics Inc., Indivior Pharmaceuticals Inc. and Supernus Pharmaceuticals Inc.
What company is Jack A. Khattar the CEO of?
Jack A. Khattar is President, CEO of Supernus Pharmaceuticals Inc. and Jack A. Khattar has been Chief Executive Officer of Indivior Pharmaceuticals Inc. since November 2026.
How long has Jack A. Khattar served on boards?
Our records show at least 7 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.